The Germany oncology information system market is estimated to grow at a CAGR of 7.3% during the forecast period to reach nearly $200 million in 2025 from $120 million in 2018. Germany is one of the major economies in Europe which is considerably influencing the European oncology information system market. Well-developed healthcare infrastructure coupled with the increased penetration of digitalization and the significant prevalence of cancer in the country is expected to surge the oncology information system market size within the country.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/germany-oncology-information-system-market

This is largely due to the increasing geriatric population owing to which the risk associated with numerous types of cancers is expected to increase significantly in the future years. Moreover, the presence of highly specialized urologists for cancer treatment and a more feasible cost compared to UK attracting medical tourism in the country is also expected to create opportunities for the augmentation of the market in the near future. The prevalence rate of cancer has been increasing in Germany.

A Full Report of Germany Oncology Information System Market is Available at: https://www.omrglobal.com/industry-reports/germany-oncology-information-system-market

The Germany Oncology Information System market is segmented on the basis of oncology type and end-user. On the basis of oncology type, the market is segmented into medical oncology, radiation oncology, and surgical oncology. Medical oncology segment dominated the market in 2018 and is further estimated to continue the same trend over the forecast period. Medical oncology includes immunotherapy, chemotherapy, targeted therapy, and hormonal therapy. With the increasing number of cancer cases, the use of these therapies increases, which in turn, drives the segmental growth of the market.

In addition, the key players such as Elekta AB, Verian Medical Systems, Inc., and Cerner Corp., contribute significantly to the segmental growth of the market. For instance, MOSAIQ Medical Oncology system offered by Elekta AB efficiently manage all the chemotherapy program, ranging from diagnosis to treatment post-follow-up. Additionally, it manages medical record of patient for multiple treatment types and reduces errors and inefficiencies. Furthermore, based on the end-user, the market is classified into hospitals and clinics, diagnostic centers, and others.


Germany Oncology Information System Market Segmentation
Germany Oncology Information System Market by Oncology Type
• Medical Oncology
• Surgical Oncology
• Radiation Oncology


Germany Oncology Information System Market by End-User
• Hospitals & Clinics
• Diagnostic Centers
• Others (Research Institute)


Germany Oncology Information System Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Accuray, Inc.
• AdvancedMD, Inc.
• Allscripts Healthcare Solutions, Inc.
• Bizmatics, Inc.
• Carevive Systems, Inc.
• Cerner Corp.
• Elekta AB
• Epic Systems Corp.
• F. Hoffmann-La Roche AG
• IBM Corp.
• Koninklijke Philips N.V.
• Mckesson Corp.
• Medical Information Technology, Inc.
• RaySearch Laboratories AB
• Siemens AG
• Syapse Inc.
• Varian Medical Systems, Inc.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-oncology-information-system-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404